Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tumor Suppressor Protein p53 | 7 | 2019 | 3552 | 0.970 |
Why?
|
| Regulatory-Associated Protein of mTOR | 1 | 2020 | 16 | 0.770 |
Why?
|
| AMP-Activated Protein Kinases | 3 | 2020 | 413 | 0.750 |
Why?
|
| Metformin | 1 | 2020 | 378 | 0.570 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2019 | 621 | 0.560 |
Why?
|
| Embryonic Development | 4 | 2019 | 306 | 0.520 |
Why?
|
| CHARGE Syndrome | 1 | 2014 | 11 | 0.500 |
Why?
|
| Embryo, Mammalian | 5 | 2019 | 741 | 0.480 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 4053 | 0.340 |
Why?
|
| Abnormalities, Multiple | 1 | 2014 | 998 | 0.310 |
Why?
|
| Phenotype | 3 | 2019 | 6295 | 0.260 |
Why?
|
| Signal Transduction | 2 | 2020 | 11965 | 0.220 |
Why?
|
| Mice | 10 | 2024 | 34495 | 0.210 |
Why?
|
| Mice, Knockout | 5 | 2019 | 5710 | 0.200 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2019 | 1498 | 0.200 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2020 | 1546 | 0.200 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2016 | 5319 | 0.190 |
Why?
|
| Metabolism | 1 | 2020 | 55 | 0.190 |
Why?
|
| Gene Knock-In Techniques | 1 | 2020 | 171 | 0.180 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2019 | 22 | 0.180 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 7222 | 0.170 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2020 | 265 | 0.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 8873 | 0.170 |
Why?
|
| Neural Crest | 1 | 2019 | 85 | 0.170 |
Why?
|
| Animals | 10 | 2024 | 59536 | 0.160 |
Why?
|
| Cell Cycle Checkpoints | 2 | 2019 | 278 | 0.150 |
Why?
|
| Tumor Protein p73 | 1 | 2017 | 105 | 0.150 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2016 | 54 | 0.140 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 586 | 0.140 |
Why?
|
| Lung Neoplasms | 2 | 2016 | 11538 | 0.140 |
Why?
|
| Thiophenes | 1 | 2016 | 148 | 0.130 |
Why?
|
| Gene Order | 1 | 2015 | 111 | 0.130 |
Why?
|
| Ear | 1 | 2014 | 38 | 0.120 |
Why?
|
| Pyrimidinones | 1 | 2016 | 314 | 0.120 |
Why?
|
| Hearing Loss, Conductive | 1 | 2014 | 15 | 0.120 |
Why?
|
| Maxillofacial Abnormalities | 1 | 2014 | 11 | 0.120 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 246 | 0.120 |
Why?
|
| Gene Targeting | 1 | 2015 | 292 | 0.120 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2014 | 69 | 0.120 |
Why?
|
| Fatty Acids | 1 | 2016 | 448 | 0.120 |
Why?
|
| Mutant Proteins | 1 | 2014 | 234 | 0.110 |
Why?
|
| Lysosomes | 1 | 2016 | 347 | 0.110 |
Why?
|
| Cell Lineage | 1 | 2016 | 668 | 0.110 |
Why?
|
| Graft vs Host Disease | 1 | 2024 | 2638 | 0.110 |
Why?
|
| Limb Deformities, Congenital | 1 | 2014 | 112 | 0.110 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 483 | 0.110 |
Why?
|
| Cell Proliferation | 2 | 2016 | 7226 | 0.110 |
Why?
|
| Genetic Loci | 1 | 2015 | 481 | 0.110 |
Why?
|
| Craniofacial Abnormalities | 1 | 2014 | 239 | 0.110 |
Why?
|
| Phosphorylation | 1 | 2020 | 4804 | 0.110 |
Why?
|
| Genotype | 1 | 2020 | 4109 | 0.110 |
Why?
|
| Mitochondria | 1 | 2019 | 1282 | 0.100 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2016 | 1331 | 0.100 |
Why?
|
| Phosphoproteins | 1 | 2017 | 1152 | 0.100 |
Why?
|
| DNA Helicases | 1 | 2014 | 434 | 0.100 |
Why?
|
| Heterozygote | 1 | 2014 | 1020 | 0.100 |
Why?
|
| DNA-Binding Proteins | 2 | 2014 | 4821 | 0.100 |
Why?
|
| Inflammation | 1 | 2020 | 2522 | 0.090 |
Why?
|
| Trans-Activators | 1 | 2017 | 1555 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 507 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 1362 | 0.090 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 1070 | 0.090 |
Why?
|
| Gene Deletion | 1 | 2014 | 1442 | 0.090 |
Why?
|
| Energy Metabolism | 1 | 2015 | 992 | 0.080 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 1879 | 0.080 |
Why?
|
| Autophagy | 1 | 2015 | 927 | 0.080 |
Why?
|
| Alleles | 1 | 2014 | 2437 | 0.080 |
Why?
|
| Fibroblasts | 1 | 2014 | 1682 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 3101 | 0.070 |
Why?
|
| Protein Binding | 1 | 2014 | 3438 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 2359 | 0.070 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2024 | 6550 | 0.070 |
Why?
|
| Cell Differentiation | 1 | 2016 | 4078 | 0.060 |
Why?
|
| Apoptosis | 2 | 2019 | 7591 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 14551 | 0.040 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2019 | 39 | 0.040 |
Why?
|
| Yolk Sac | 1 | 2019 | 26 | 0.040 |
Why?
|
| Intestines | 1 | 2024 | 686 | 0.040 |
Why?
|
| Genes, Lethal | 1 | 2019 | 120 | 0.040 |
Why?
|
| Neural Tube | 1 | 2019 | 51 | 0.040 |
Why?
|
| Female | 4 | 2019 | 141928 | 0.040 |
Why?
|
| Mesoderm | 1 | 2019 | 404 | 0.040 |
Why?
|
| Allosteric Regulation | 1 | 2016 | 68 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2024 | 1818 | 0.040 |
Why?
|
| Endoderm | 1 | 2016 | 55 | 0.030 |
Why?
|
| Acetyltransferases | 1 | 2016 | 143 | 0.030 |
Why?
|
| Placenta | 1 | 2019 | 516 | 0.030 |
Why?
|
| Embryonic Stem Cells | 1 | 2016 | 301 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2016 | 430 | 0.030 |
Why?
|
| Heart | 1 | 2019 | 1223 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2024 | 3869 | 0.020 |
Why?
|
| Humans | 3 | 2016 | 261506 | 0.020 |
Why?
|
| Male | 2 | 2019 | 123000 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 6942 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 3821 | 0.020 |
Why?
|
| Pregnancy | 1 | 2019 | 7573 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 2330 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 2195 | 0.020 |
Why?
|
| Mutation | 1 | 2016 | 15179 | 0.010 |
Why?
|